Pharmaceutical

Filter

Current filters:

None

Popular Filters

6526 to 6550 of 7088 results

Irish pharma sees failures in ESRI report on use of pharmaceuticals

30-01-2012

A new report by Ireland’s Economic and Social Research Institute (ESRI) has recommended new ways…

BiotechnologyEuropePharmaceuticalPricingRegulation

Positive data for BTG’s Varisolve

30-01-2012

UK specialist health care firm BTG (LSE: BGC) has announced the successful outcome of VANISH-2, the first…

BTGCardio-vascularPharmaceuticalResearchVarisolve

FDA finally approves Bydureon

30-01-2012

There was good news on Friday for USA-based Amylin Pharmaceuticals (Nasdaq: AMLN) and Alkermes (Nasdaq:…

AlkermesAmylinBydureonDiabetesEli LillyNorth AmericaPharmaceuticalRegulation

EC and Italian government seek to boost generic medicine use

30-01-2012

The European Commission’s formal call last week on Italy to comply with European Union rules on…

EuropeGenericsMarkets & MarketingPatentsPharmaceuticalPoliticsRegulation

FDA OKs Pfizer’s Inlyta and accepts NDA for bosutinib

30-01-2012

The US Food and Drug Administration on Friday approved global pharma behemoth Pfizer’s (NYSE: PFE)…

bosutinibInlytaNorth AmericaOncologyPfizerPharmaceuticalRegulation

Germany’s IQWiG finds “hint” of advantage for Novartis’ Gilenya

30-01-2012

The German Institute for Quality and Efficiency in Health Care (IQWiG) has assessed whether Swiss drug…

EuropeGilenyaNeurologicalNovartisPharmaceuticalPricingRegulation

EC closes procedural case against Servier

29-01-2012

The European Commission said last Friday that it has closed an investigation into Fremch independent…

EuropeGenericsMarkets & MarketingPharmaceuticalRegulationServier

LEO Pharma gets FDA nod for Picato

29-01-2012

Independent Danish drugmaker LEO Pharma says that the US Food and Drug Administration has approved its…

DermatologicalsLEO PharmaNorth AmericaPharmaceuticalPicatoRegulation

GenVec extends research deal with Novartis

29-01-2012

US biopharma company GenVec (Nasdaq: GNVC) says that it has extended its research collaboration and license…

BiotechnologyGenVecNeurologicalNovartisPharmaceuticalResearch

French government delists certain Ipsen products

29-01-2012

French drugmaker Ipsen (Euronext: IPN) announced the French government’s decision to no longer reimburse…

EuropeGingko bilobaIpsenMarkets & MarketingNeurologicalPharmaceuticalRegulation

Celgene to buy Avila; posts strong 4th-qtr results

27-01-2012

USA-based Celgene (Nasdaq: CELG) yesterday revealed that it has entered into a definitive merger deal…

Avila TherapeuticsBiotechnologyCelgeneFinancialMergers & AcquisitionsOncologyPharmaceutical

Bristol-Myers fourth quarter below analysts estimates

27-01-2012

US drug major Bristol-Myers Squibb (NYSE: BMY) posted fourth quarter 2011 net sales of $5.5 billion,…

Bristol-Myers SquibbFinancialPharmaceutical

Kenya court set to deliver ruling on anti-counterfeit law

27-01-2012

After almost three years of waiting since three petitioners living with HIV filed a constitutional petition…

GenericsLegalMarkets & MarketingPharmaceuticalRest of the World

Illumina implements “poison pill” with regard to Roche bid

27-01-2012

Responding to Swiss drug major Roche’s (ROG: SIX) hostile takeover over offer of $44.50 per share…

IlluminaMergers & AcquisitionsPharmaceuticalRoche

Deal-making declines as Pharma tighten its belt

26-01-2012

Overall pharmaceutical deal-making activity fell by 18% in 2011 as pharmaceutical companies cut R&D expenditure…

BiotechnologyGlobalLicensingPharmaceutical

Gardasil does not trigger autoimmune conditions; study

26-01-2012

US drug giant Merck & Co’s (NYSE: MRK) Gardasil ([human papillomavirus quadrivalent [types 6, 11,…

GardasilMen's HealthMerck & CoNorth AmericaPharmaceuticalResearchVaccinesWomen's Health

Spectrum Pharma to acquire non-US rights to market Zevalin

26-01-2012

USA-based Spectrum Pharmaceuticals (NasdaqGS: SPPI) says it has entered into an agreement to acquire…

BayerMergers & AcquisitionsOncologyPharmaceuticalSpectrum PharmaceuticalsZevalin

Abbott on track to split; posts higher earnings

26-01-2012

Despite another challenging year for the global economy, US health care major Abbott (NYSE: ABT) again…

Abbott LaboratoriesFinancialPharmaceutical

US FDA mixed views on Vytorin and Zetia

26-01-2012

US drug giant Merck & Co (NYSE: MRK) yesterday received Food and Drug Administration approval to update…

Cardio-vascularMerck & CoNephrology and HepatologyNorth AmericaPharmaceuticalRegulationVytorinZetia

BioLineRx in-licenses BL-8020, an oral hepatitis C treatment

26-01-2012

Israeli biopharma company BioLineRx (Nasdaq: BLRX) says it has signed a worldwide, exclusive license…

Anti-viralsBioLineRxGenoscienceLicensingPharmaceutical

Ipsen returns rights to Parkinson’s drug to Santhera

26-01-2012

Switzerland’s Santhera Pharmaceuticals (SIX:SANN) and French drugmaker Ipsen (Euronext: IPN) have…

fipamezoleIpsenLicensingNeurologicalPharmaceuticalSanthera Pharmaceuticals

Novartis resolves US class action on wage and hour claims

25-01-2012

The US subsidiary of Swiss drug major Novartis (NOVN: VX) says it has reached an agreement to resolve…

LegalManagementNorth AmericaNovartisPharmaceutical

Expanded use for Merck Serono’s Rebif in EU

25-01-2012

Merck Serono, the Switzerland-based division of Germany’s Merck KGaA (MRK: DE), says that that the…

EuropeMerck KGaAMerck SeronoNeurologicalPharmaceuticalRebifRegulation

Roche makes $5.7 billion hostile bid for Illumina

25-01-2012

Swiss drugs and diagnostic major Roche (ROG: SIX) announced this morning that it is proposing to acquire…

IlluminaMergers & AcquisitionsPharmaceuticalRoche

6526 to 6550 of 7088 results

Back to top